ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,519.98
      -0.44%
      US Tech 100
      19,051.20
      -0.67%
      Dow Jones
      40,368.72
      -0.73%
      Brent Oil
      82.00
      -2.47%
      Bitcoin
      67,154.78
      4.98%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ovid Therapeutics Inc (OVID)

      7. Ovid Therapeutics Inc (OVID) Financials

      Ovid Therapeutics Inc

      Ovid Therapeutics Inc (OVID)

      NASDAQ
      0.9914
      0.0338
      ( 3.53% )
      Updated: 15:04:54
      Delayed by 15 minutes

      Ovid Therapeutics Inc Financial Summary

      The current OVID market cap is 70.33M. The company's latest EPS is USD -0.7377 and P/E is -1.34.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 66k75k109k142k148k
      Operating Income -14.89M-14.17M-12.03M-18.19M-17.42M
      Net Income -13.36M-12.41M-11.25M-15.32M-11.69M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 012.62M208.38M1.5M392k
      Operating Income -61.41M-81.43M124.21M-55.55M-59.28M
      Net Income -60.46M-81.04M122.84M-54.17M-52.34M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 143.37M136.23M125.03M144.03M131.61M
      Total Liabilities 22.42M25.53M23.74M56.23M53.33M
      Total Equity 120.95M110.7M101.29M87.8M78.28M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 80.84M75.93M194.55M155.27M144.03M
      Total Liabilities 10.82M32.29M14.8M22.99M56.23M
      Total Equity 70.02M43.63M179.75M132.27M87.8M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -12.11M-23.82M-33.87M-45.78M-16.69M
      Investing 30.23M50.3M45.94M-2.58M20.19M
      Financing 67k278k502k30.54M228k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -51.09M-51.58M118.61M-55.23M-45.78M
      Investing -30.04M34.65M-1.82M-87.88M-2.58M
      Financing 86.54M47.07M903k181k30.54M

      Stats and Ratios

      Market Cap 70.33M
      Price to Earnings Ratio -1.34
      Price to Sales Ratio 180
      Price to Cash Ratio 2.6
      Price to Book Ratio 0.8
      Dividend Yield -

      Share Statistics

      Shares Outstanding 70.94M
      Average Volume (1 week) 435.9k
      Average Volume (1 Month) 1.04M
      52 Week Change -72.07%
      52 Week High 4.1389
      52 Week Low 0.68
      Spread (Intraday) 0.01 (1.46%)

      Company Info

      Company Name Ovid Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://ovidrx.com
      Industry pharmaceutical preparations (2834)